Withdrawal-induced antihypertensive effect of vasopressin: Role of the L-arginine/nitric oxide pathway

Canadian Journal of Physiology and Pharmacology

Volumn 75, Issue 7, 1997, Pages 812-817

  Tatchum Talom, R ^a   McNeill, J R ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Blood pressure; Hypertension; L arginine; Nitric oxide; Vasopressin

Indexed keywords

ARGIPRESSIN; N(G) NITROARGININE; NITRIC OXIDE; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ARGININE; ARGININE VASOPRESSIN; BLOOD PRESSURE; ENZYME INHIBITORS; HYPERTENSION; MALE; NITRIC OXIDE; NITROARGININE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME; VASOCONSTRICTOR AGENTS;

EID: 0030869936     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/cjpp-75-7-812     Document Type: Article

References (4)

1. Brown, A.J., Lohmeier, T.E., Carroll, R.G., and Meydrech, E.F. 1986. Cardiovascular and renal responses to chronic vasopressin infusion. Am. J. Physiol. 250: H584-H594.
2. Chen, R.Y., and Sanders, P.W. 1996. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J. Clin. Invest. 88: 1559-1567.
3. Chiu, E.K.Y., and McNeill, J.R. 1987. Pretreatment with vasodilator or VI-antagonist abolishes vasopressin withdrawal hypotension in spontaneously hypertensive rats. J. Hypertens. 5: 593-598.
4. Chiu, E.K.Y., and McNeill, J.R. 1989a. Withdrawal-induced antihypertensive effect of vasopressin in DOCA-salt hypertension. Am. J. Hypertens. 2: 458-461.